Integrated Proteins Ltd (519606) — Multibagger Analysis

AI research on 1 Expansion / Order-win announcement by Integrated Proteins Ltd since August 2026 — deal magnitude, revenue and EPS impact, execution risk, and the actual return since each announcement measured from the next trading day's open and benchmarked against the Nifty Smallcap 250.

1
Announcements analysed
0
Strong candidates
25/100
Best multibagger score

Board Meeting - Outcome of Board Meeting

· Expansion · Unlikely · Edible Oil · score 25/100
Deal
Deal value—
Deal vs businessQ1 FY27 revenue (₹10.55 Cr) exceeds total FY26 annual revenue (₹9.94 Cr) by 1.06x
Execution period1.0 yr
Fundamental gradeD
AI projections
Revenue uplift (yr1 / steady)324.5% / 324.5%
EPS uplift533.3%
Upside base / bull / bear-20.0% / 30.0% / -60.0%
Horizon12-24 months
Realized market record
Entry — next-day open (17 Aug 2026)₹14.1
Latest close (16 Sep 2026)₹14.05
Return since-0.4%
α vs Smallcap 250+2.0%
Positives
  • Q1 FY27 revenue reached ₹10.55 Cr, exceeding full FY26 sales in a single quarter
  • Net profit turned positive to ₹0.36 Cr versus ₹0.01 Lakhs YoY
  • Zero debt balance sheet provides short-term flexibility
Risks
  • Promoter holding is critically low at 2.23%, indicating negligible promoter skin in the game
  • Abrupt pivot from Edible Oils to Textiles (99.6% of sales) raises questions on revenue sustainability and working capital risks
  • Extremely rich valuation with trailing P/E at 1130x and market cap of ₹249 Cr against tiny absolute earnings
  • Thin operating profit margins (~3.4%) leave zero margin for operational error
Governance flags
  • Promoter holding collapsed to 2.23% (severely below the 35% threshold)
  • Abrupt shift in core business model into unrelated textile trading/processing without clarity on counterparties or working capital funding
Full AI brief

Analyst Report: Integrated Proteins Ltd (519606)

1. Announcement Analysis & Ramp-Aware Impact Math

Integrated Proteins reported Q1 FY27 revenue of ₹10.55 Cr, representing a massive surge compared to ₹0.05 Cr in Q1 FY26 and higher than the total FY26 annual revenue of ₹9.94 Cr. Net profit stood at ₹0.36 Cr for the quarter (EPS ₹0.19).

  • Ramp-Aware Math:
  • Annualized Q1 revenue = ~₹42.2 Cr (vs FY26 revenue of ₹9.94 Cr, an uplift of ~324.5%).
  • Operating profit for Q1 FY27 stood at ~₹0.36 Cr (~3.4% margin).
  • Annualized PAT = ~₹1.44 Cr -> Annualized EPS = ~₹0.76 (vs FY26 EPS of ₹0.12, an uplift of ~533%).
  • At the current market price of ₹135.7 (Market Cap ₹249 Cr), the forward P/E on annualized Q1 earnings is ~173x, while trailing P/E remains extreme at 1130x.

2. Industry Context & Quality Assessment

  • Pivot to Textile Segment: 99.6% of Q1 FY27 revenue (₹10.51 Cr) came from Textiles, representing a complete pivot away from Edible Oils. Textile trading/processing is characterized by medium capital intensity, low operating margins (typically 3-6%), and high working capital dependency.
  • Quality Metrics: ROCE sits at 1.3%, OPM at 2.4%, and net worth at ₹21 Cr. Fundamental Grade is D due to weak structural profitability.

3. Governance & Risk Constraints (Mandatory Cap Rule)

  • Promoter Stake Risk: Promoter holding stands at a dangerously low 2.23% (down from 13.04% in Sep 2025). Per evaluation guardrails, any stock with promoter holding < 35% MUST be capped at POSSIBLE or lower, with confidence <= 0.50.
  • Business Model Pivot: An abrupt transition into textile trading with low promoter ownership raises severe red flags regarding revenue quality, counterparty concentration, and corporate governance.

4. Valuation Scenarios & Target Impact

  • Bull Case (+30%): Textile revenues scale sustainably to >₹60 Cr annually with margin expansion to 6%, pushing annual PAT to ₹3.6 Cr. Forward P/E compresses towards ~70x.
  • Base Case (-20%): Revenue stabilizes around ₹40 Cr with razor-thin net margins (~3%), yielding PAT of ~₹1.2-1.5 Cr. Stock de-rates towards realistic industry multiples (Peer median P/E is 22.9x).
  • Bear Case (-60%): Revenue jump proves to be a temporary pass-through trading spike, margins compress back to near-zero, and lack of promoter backing leads to significant price destruction.

5. Final Verdict & Recommendation

While the Q1 earnings show a dramatic top-line surge, the combination of an abrupt business pivot, razor-thin margins, an extreme valuation (>170x forward P/E), and a critical promoter holding of just 2.23% makes this an UNLIKELY multibagger candidate. Confidence is set low at 0.35.

Analysis as of 2026-08-14 (price ₹135.65) · AI research, not investment advice.
FollowTelegram

Verdicts and projections on this page are produced by an AI model from Integrated Proteins Ltd's public exchange filings and are not investment advice. "Return since" is measured from the opening price of the next trading day after each announcement to the latest available close, so it reflects a price an investor could actually have paid. See all analysed companies on Multibagger AI.

⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI